These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 11820865)
41. [Trimetazidine in the treatment of stable angina pectoris TRIADA-(trimetazidine in stable angina twice daily)]. Chaloupka V Vnitr Lek; 2006 Jun; 52(6):609-14. PubMed ID: 16871765 [TBL] [Abstract][Full Text] [Related]
42. Effective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injury. Şentürk T; Çavun S; Avcı B; Yermezler A; Serdar Z; Savcı V Atherosclerosis; 2014 Dec; 237(2):760-6. PubMed ID: 25463117 [TBL] [Abstract][Full Text] [Related]
43. The effect of trimetazidine added to pharmacological treatment on all-cause mortality in patients with systolic heart failure. Grajek S; Michalak M Cardiology; 2015; 131(1):22-9. PubMed ID: 25832112 [TBL] [Abstract][Full Text] [Related]
44. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties. Kutala VK; Khan M; Mandal R; Ganesan LP; Tridandapani S; Kalai T; Hideg K; Kuppusamy P J Pharmacol Exp Ther; 2006 Jun; 317(3):921-8. PubMed ID: 16467453 [TBL] [Abstract][Full Text] [Related]
45. Potential interest of anti-ischemic agents for limiting cyclosporin A nephrotoxicity. Simon N; Tillement JP; Albengres E; Jaber K; Hestin D; Roux F; Olivier P; d'Athis P; Kessler M; Berland Y; Crevat A Int J Clin Pharmacol Res; 1997; 17(4):133-42. PubMed ID: 9526174 [TBL] [Abstract][Full Text] [Related]
46. [Observation on effect of compound danshen droplet-pill combined with trimetazidine in treating senile unstable angina pectoris]. Qiu ZX; Ma HJ; Wang DF Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Sep; 25(9):787-9. PubMed ID: 16248238 [TBL] [Abstract][Full Text] [Related]
48. Angina, myocardial hibernation and trimetazidine. Jackson G Int J Clin Pract; 1997 Sep; 51(6):347. PubMed ID: 9489058 [No Abstract] [Full Text] [Related]
49. Effect of trimetazidine on xanthine oxidoreductase expression in rat kidney with ischemia--reperfusion injury. Sulikowski T; Domanski L; Ciechanowski K; Adler G; Pawlik A; Safranow K; Dziedziejko V; Chlubek D; Ciechanowicz A Arch Med Res; 2008 May; 39(4):459-62. PubMed ID: 18375259 [TBL] [Abstract][Full Text] [Related]
50. Trimetazidine improves exercise tolerance in patients with ischemic heart disease : A meta-analysis. Zhao Y; Peng L; Luo Y; Li S; Zheng Z; Dong R; Zhu J; Liu J Herz; 2016 Sep; 41(6):514-22. PubMed ID: 26668006 [TBL] [Abstract][Full Text] [Related]
51. Trimetazidine improves right ventricular function by increasing miR-21 expression. Liu F; Yin L; Zhang L; Liu W; Liu J; Wang Y; Yu B Int J Mol Med; 2012 Oct; 30(4):849-55. PubMed ID: 22842854 [TBL] [Abstract][Full Text] [Related]
52. Trimetazidine an emerging paradigm in renal therapeutics: Preclinical and clinical insights. Gupta K; Pandey S; Bagang N; Mehra K; Singh G Eur J Pharmacol; 2021 Dec; 913():174624. PubMed ID: 34774496 [TBL] [Abstract][Full Text] [Related]
53. Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice. Glezer MG; Vygodin VA; Adv Ther; 2018 Sep; 35(9):1368-1377. PubMed ID: 30105656 [TBL] [Abstract][Full Text] [Related]
54. [Value of trimetazidine in the long-term treatment of cardiomyopathies of ischemic origin]. Brottier L; Barat JL; Combe C; Boussens B; Bonnet J; Bricaud H Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):179-82. PubMed ID: 2735733 [TBL] [Abstract][Full Text] [Related]
55. Effect of trimetazidine on the nucleotide profile in rat kidney with ischemia-reperfusion injury. Domanski L; Sulikowski T; Safranow K; Pawlik A; Olszewska M; Chlubek D; Urasinska E; Ciechanowski K Eur J Pharm Sci; 2006 Mar; 27(4):320-7. PubMed ID: 16387483 [TBL] [Abstract][Full Text] [Related]
56. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy. Fragasso G; Piatti Md PM; Monti L; Palloshi A; Setola E; Puccetti P; Calori G; Lopaschuk GD; Margonato A Am Heart J; 2003 Nov; 146(5):E18. PubMed ID: 14597947 [TBL] [Abstract][Full Text] [Related]
58. The prevalence of trimetazidine use in athletes in Poland: excretion study after oral drug administration. Jarek A; Wójtowicz M; Kwiatkowska D; Kita M; Turek-Lepa E; Chajewska K; Lewandowska-Pachecka S; Pokrywka A Drug Test Anal; 2014; 6(11-12):1191-6. PubMed ID: 25421604 [TBL] [Abstract][Full Text] [Related]
59. Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease. Costa LMA; Rezende PC; Garcia RMR; Uchida AH; Seguro LFBC; Scudeler TL; Bocchi EA; Krieger JE; Hueb W; Ramires JAF; Filho RK Medicine (Baltimore); 2015 Aug; 94(33):e1161. PubMed ID: 26287407 [TBL] [Abstract][Full Text] [Related]
60. Nonsynergistic effects of trimetazidine and selenium combination therapy on renal ischemic-reperfusion injury in rats. Karayaylali I; Emre M; Seyrek N; Yildiz SM; Erdogan S; Balal M; Paydas S; Tuncer I; Alparslan N Adv Ther; 2004; 21(1):47-60. PubMed ID: 15191157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]